Publication | Closed Access

2-Alkylamino- and alkoxy-substituted 2-amino-1,3,4-oxadiazoles—O-Alkyl benzohydroxamate esters replacements retain the desired inhibition and selectivity against MEK (MAP ERK kinase)

Molecular PharmacologyMedicinal ChemistryBiochemistryMedicineNatural SciencesDesired InhibitionMechanism Of ActionMap Erk KinasePharmacologyPharmaceutical ChemistryInhibitory ActivityDrug Discovery